has anti-inflammatory and anti-bacterial activities. Staphylococcus aureus (S. aureus)-producing lipoteichoic acid (LTA) has been implicated in inflammatory and immunologic responses in patients with atopic dermatitis (AD). The purpose of this study was to determine the potential of H. cordata as a novel anti-inflammatory agent for AD by evaluating the anti-inflammatory activity of H. cordata water extract on LTA-induced inflammation in dermal fibroblasts (DFs). The anti-inflammatory activity of H. cordata was evaluated by studying the inflammatory markers tumor necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2). As shown by MTT assay and COX-2 immunoblot, H. cordata was not toxic to DFs in doses up to 20μg/ml. In RT-PCR and Western blot analysis, LTA up-regulated TNF-α (mRNA) and COX-2 (protein) at doses of 5∼20μg/ml in a dose-dependent manner. Next, DFs were treated with LTA (10μg/ml) in the absence (control) or presence of H. cordata for 24 h. The level of LTA-induced TNF-α mRNA was suppressed by H. cordata (20μg/ml) by up to 40% compared with the level in LTA-treated control samples. Under the same conditions, the level of LTA-induced COX-2 protein was suppressed by H. cordata treatment by up to 52% compared with the level in LTA-treated control samples. When DFs were treated with TNF-α (10μg/ml) for 24 h, TNF-α-induced COX-2 expression was down-regulated by H. cordata treatment to 65% of that in control samples. In conclusion, H. cordata has anti-inflammatory activity against LTA-induced inflammation in DFs, in part by blocking the TNF-α pathway.
Introduction
Houttuynia cordata (H. cordata) is a traditional medicinal plant that is used in herbal preparations in Asian countries to relieve inflammatory conditions. H. cordata has been shown to have strong anti-inflammatory activity in a pleurisy model and in ear edema. 1 H. cordata has been used as an anti-inflammatory agent for treating atopic dermatitis (AD) and acne in traditional Korean herbal medicine.
With respect to the mechanism by which AD inflammation is induced, Staphylococcus aureus has been widely studied for its active roles in inflammatory and immunologic responses against AD. 2 Lipoteichoic acid (LTA) acts as an adhesion molecule for many Grampositive bacteria, including staphylococci, streptococci, and pneumococci. 3 Recently, LTA was extensively studied in relation to the pathogenic role of S. aureus in AD inflammation. 4 S. aureus cell walls are composed of highly crosslinked peptidoglycans (PEGs) decorated with teichoic acid (TA) polymers, which are also linked to plasma membrane phospholipids, of which LTA and PEG are the major surface components. 5 TA or related glycopolymers play crucial roles in bacterial survival under suboptimal conditions and in other basic cellular processes. 3, 4 In AD, LTA induces IL-5 production from peripheral blood mononuclear cells (PBMCs) and AD-like skin lesions with the T helper type 2 (Th2) response, including the production of IL-4 and IL-5. 5 Tumor necrosis factor (TNF)-α has a number of pro-inflammatory effects in skin inflammation and therefore has been studied extensively as a therapeutic target in treating TNF-α-mediated skin disorders, such as AD and psoriasis. 6 In skin affected by AD, local tissue expression of pro-inflammatory cytokines and chemokines has focused on epidermal keratinocytes (KCs), T lymphocytes, dendritic cells, macrophages, mast cells, and eosinophils. 7 S. aureus induces the production of major pro-inflammatory cytokines, including TNF-α, interleukin-1 (IL-1), IL-6, and IL-8
from KCs in the epidermis or from PBMCs, which are infiltrated into the dermis. 8, 9 However, dermal fibroblasts (DFs) have been reported to be another source of TNF-α production by various external stimuli. [10] [11] [12] In this study, we determined whether DFs can be another source of production following stimulation by LTA. COX-2 is also a good biomarker for inflammation in various tissues, including skin, as it has been widely studied in relation to tissue inflammation, wounds or ulcer healing, and carcinogenesis. 13 In this study, we used TNF-α and COX-2 as representative inflammatory markers. incubator. DFs from passages 2 to 4 were used for all experiments. The primary cultured cells were confirmed to be DFs by immunostaining with vimentin ( Fig. 1 ).
MTT assay
To determine cell viability, the cells were seeded into 
Statistics
All experiments were carried out in triplicate, and the results are expressed as the mean ± standard deviation. Comparisons between samples were carried out by using Student's t-test with statistical significance considered to be p＜0.05.
Results

LTA induces up-regulation of TNF-α and COX-2 in
DFs
As a preliminary experiment, we evaluated the optimal concentration of an H. cordata extract. As shown by the MTT assay, the viability of the DFs was not significantly affected by H. cordata at doses of 1∼100μg/ml ( Fig.   2A ). However, COX-2 protein expression was stimulated by the highest dose of H. cordata at 50μg/ml (Fig. 2B) , implying a toxic response of DFs to H. cordata. There was no effect of H. cordata treatment on TNF-α expression ( Fig. 2C) . Thus, the next experiments with H. cordata were performed at concentrations up to 20μg/ml.
Among the pro-inflammatory molecules involved in the pathogenesis of AD inflammation, TNF-α was shown to be a major cytokine in inducing AD inflammation. 6 In DFs treated with LTA (10μg/ml) for 24 h, the level of TNF-α mRNA based on RT-PCR was up-regulated in a dose-dependent manner (Fig. 3A) . As shown by Western blot analysis, the level of COX-2 protein was up-regulated with a positive correlation between the LTA dose and COX-2 level (Fig. 3B ).
H. cordata inhibits LTA-induced TNF-α and COX-2 expression in DFs
We next evaluated whether H. cordata had antiinflammatory activity in LTA-induced inflammation in DFs. When DFs were treated with H. cordata extract at doses of 20μg/ml for 24 h, the level of LTA (10μg/ ml)-induced TNF-α mRNA was reduced to approximately 40% of LTA-treated control samples (p＜0.05, n=3) ( Fig. 4 ). Under the same conditions, the level of LTA-induced COX-2 protein was reduced to 52% of that in LTA-treated control samples (p＜0.05, n=3) ( Fig. 5 ).
H. cordata inhibits TNF-α-induced COX-2 expression in DFs
From the results that LTA could induce TNF-α mRNA expression, we evaluated whether H. cordata had anti-inflammatory activity in TNF-α-treated DFs.
When DFs were treated with H. cordata extract at doses of 20μg/ml for 24 h, TNF-α-induced COX-2 expression was reduced to 65% of that in TNF-αtreated control samples (p＜0.05, n=3) ( Fig. 6 ).
Discussion
H. cordata is a native herbaceous plant in many Asian countries. H. cordata has been used to treat various infectious conditions owing to its anti-viral activ ity against herpes virus type 1, influenza virus, and human immunodeficiency 16 and its antibacterial activity against S. aureus, Sarcina ureae, (P. acnes), 18 and Salmonella typhimurium. 19 H. cordata also has other biological activities, such as anti-inflammatory, 19 anti-cancer, 20 10, 11 implying that UV radiation or proinflammatory stimuli induce the production of TNF-α from both cells. In agreement with our previous report that P. acnes induced TNF-α production from DFs, 12 this study showed that LTA also stimulates the production of TNF-α from DFs.
Because the inflammatory reaction of AD takes place in the dermis rather than the epidermis, our results suggest that DFs are not only a target of TNF-α that is produced by other cells (KCs and inflammatory cells) but also a source for TNF-α expression by LTA stimulation. When DFs were treated with TNF-α, H.
cordata had an inhibitory effect against TNF-α-induced COX-2 expression.
Among the three isoforms of COX, COX-2 is widely studied owing to its diverse physiologic and pathologic processes, including inflammation. COX-2 is also induced in response to inflammatory stimuli, such as UV radiation, lipopolysaccharide (LPS), and 12-Otetradecanoylphorbol 13-acetate (TPA) or phorbol ester in the skin. 13, [25] [26] [27] In this study, we used TNF-α and COX-2 as inflammatory markers of DFs.
The cytokine production by LTA is similar to that induced by whole bacteria. 28 LTA from S. aureus can promote the induction of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 from monocytes or macrophages, 29 
